We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+11.13%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.06%
5 Year Est. Return
+670.57%
10 Year Est. Return
AUM
$3.64B
AUM Growth
+$1.06B
Cap. Flow
+$1.12B
Cap. Flow %
30.83%
Top 10 Hldgs %
68.78%
Holding
808
New
139
Increased
187
Reduced
197
Closed
200

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$236M
2
AAPL icon
Apple
AAPL
+$208M
3
AMD icon
Advanced Micro Devices
AMD
+$150M
4
AMZN icon
Amazon
AMZN
+$123M
5
NKE icon
Nike
NKE
+$93.7M

Sector Composition

Rank Sector Weight
1 Technology 34.19%
2 Financials 17.54%
3 Healthcare 17.47%
4 Communication Services 13.83%
5 Consumer Discretionary 9.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.65T
$717M 19.72%
5,805,368
-1,666,752
-22% -$169M
META icon
2
Meta Platforms (Facebook)
META
$1.5T
$390M 10.73%
773,655
+486,023
+169% +$236M
COIN icon
3
Coinbase
COIN
$43.2B
$331M 9.1%
1,488,975
-52,929
-3% -$12.2M
AAPL icon
4
Apple
AAPL
$5.04T
$283M 7.79%
1,344,487
+1,114,519
+485% +$208M
RNAM
5
DELISTED
Avidity Biosciences
RNAM
$210M 5.76%
5,129,103
-500,000
-9% -$14.3M
AMD icon
6
Advanced Micro Devices
AMD
$714B
$157M 4.31%
967,231
+933,783
+2,792% +$150M
AMZN icon
7
Amazon
AMZN
$2.47T
$131M 3.61%
679,086
+667,289
+5,656% +$123M
PTCT icon
8
PTC Therapeutics
PTCT
$6.17B
$115M 3.16%
3,756,469
+30,843
+0.8% +$999K
GOOG icon
9
Alphabet (Google) Class C
GOOG
$4.1T
$91.7M 2.52%
+500,000
New +$85.1M
NKE icon
10
Nike
NKE
$63.4B
$76M 2.09%
+1,007,841
New +$93.7M
TARS icon
11
Tarsus Pharmaceuticals
TARS
$2.52B
$59.7M 1.64%
2,197,385
+74,855
+4% +$2.52M
TSLA icon
12
Tesla
TSLA
$1.19T
$47.4M 1.3%
+239,384
New +$41.8M
STOK icon
13
Stoke Therapeutics
STOK
$1.8B
$45.5M 1.25%
3,365,744
ESTA icon
14
Establishment Labs
ESTA
$2.7B
$42.7M 1.17%
939,948
PTGX icon
15
Protagonist Therapeutics
PTGX
$8.6B
$41M 1.13%
1,182,268
-375,368
-24% -$11M
BABA icon
16
Alibaba
BABA
$276B
$37.8M 1.04%
524,626
+135,083
+35% +$10.4M
SMFG icon
17
Sumitomo Mitsui Financial
SMFG
$160B
$37.6M 1.03%
2,800,730
KDK
18
Kodiak AI
KDK
$798M
$35.3M 0.97%
3,308,231
+3,000,331
+974% +$31.9M
URGN icon
19
UroGen Pharma
URGN
$1.97B
$35.2M 0.97%
2,099,482
+472,893
+29% +$6.73M
PZZA icon
20
Papa John's
PZZA
$996M
$32.7M 0.9%
+696,800
New +$38.2M
ET icon
21
Energy Transfer Partners
ET
$69.5B
$29.6M 0.81%
1,827,000
+50,000
+3% +$786K
MERC icon
22
Mercer International
MERC
$42.5M
$28.2M 0.77%
3,300,000
RCKT icon
23
Rocket Pharmaceuticals
RCKT
$336M
$23.7M 0.65%
1,100,000
MSFT icon
24
Microsoft
MSFT
$2.94T
$20.8M 0.57%
46,617
+41,639
+836% +$17.6M
ANSC
25
Agriculture & Natural Solutions Acquisition Corp
ANSC
$477M
$20.2M 0.56%
1,973,679
+637,748
+48% +$6.52M

Similar funds

Cowen and Company's Q2 2024 Portfolio in Review

As of Q2 2024, Cowen and Company held 808 positions worth $3.64B, up 41% from $2.58B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Cowen and Company deployed $1.12B of net new capital in Q2 2024, opening 139 new positions and adding to 187 existing holdings. Its largest new stake was Nike: 1,007,841 shares worth $76M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $169M trimmed.

  • Cowen and Company's largest Q2 2024 buy was Nike: 1,007,841 shares worth $76M.
  • Cowen and Company added most to Meta Platforms (Facebook) in Q2 2024, an estimated $236M increase.
  • Cowen and Company's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $169M.
  • Cowen and Company fully exited State Street SPDR S&P 500 ETF Trust in Q2 2024, selling an estimated $14.9M.
  • Cowen and Company's ten largest holdings make up 69% of its $3.64B portfolio in Q2 2024.
  • Cowen and Company opened 139 new positions and closed 200 in Q2 2024.
  • Cowen and Company's portfolio value rose 41% quarter-over-quarter to $3.64B.

Based on Cowen and Company's 13F filing for Q2 2024, filed 7 Aug 2024.